Company Overview

Steep Hill Inc. (commonly known as Steep Hill) is a cannabis and hemp analytical testing company that provides laboratory services focused on product safety, quality assurance, and regulatory compliance. The company operates within the legal cannabis, hemp, and broader life sciences testing industries, offering analytical testing for potency, contaminants, terpene profiling, and stability. Its primary customers include licensed cannabis cultivators, processors, manufacturers, and distributors operating in regulated markets.

The company is widely recognized as one of the earliest dedicated cannabis testing laboratories in the United States, having originated in California during the early development of state-regulated medical cannabis markets. Steep Hill positioned itself as a science-driven, independent testing provider, emphasizing standardized laboratory methodologies and regulatory alignment. Public information indicates the company expanded through licensing and subsidiary lab operations rather than vertically integrating into cannabis production. Data inconclusive based on available public sources regarding any current publicly traded status under the ticker STPH.

Business Operations

Steep Hill’s core business consists of laboratory testing services conducted through branded laboratory locations and licensed affiliates operating under the Steep Hill name. Revenue is generated primarily through fee-based analytical testing services required by state and local cannabis regulations, including cannabinoid potency testing, pesticide screening, microbial analysis, residual solvent testing, and terpene analysis. Operations are predominantly domestic within the United States, with no verified evidence of large-scale international laboratory operations.

The company has historically relied on a network model that includes company-owned labs and independently operated laboratories using the Steep Hill brand, testing protocols, and intellectual property. Publicly available information confirms the existence of state-specific entities such as Steep Hill Arkansas, though the full list of active subsidiaries, ownership structures, and intercompany agreements cannot be conclusively verified based on available public sources.

Strategic Position & Investments

Strategically, Steep Hill has focused on maintaining relevance in highly regulated cannabis markets by aligning its testing methodologies with evolving state compliance requirements. Growth initiatives have historically emphasized geographic expansion through new laboratory launches, licensing arrangements, and technical partnerships rather than large-scale mergers or acquisitions. No verified evidence of material acquisitions or divestitures has been disclosed through SEC filings, which appear to be absent for the company.

The company has been associated with early adoption of standardized cannabis testing protocols and has participated in industry-wide discussions around laboratory accreditation and scientific best practices. However, information regarding current investments in emerging technologies, proprietary platforms, or external portfolio companies is limited, and data inconclusive based on available public sources.

Geographic Footprint

Steep Hill’s operational footprint is concentrated in the United States, with historical and current activity in multiple state-regulated cannabis markets. The company originated in California, which remains its most prominently referenced market, and has operated or licensed laboratories in additional states where cannabis testing is mandated by law.

There is no independently verified evidence of sustained operations or laboratory facilities outside North America. While the Steep Hill brand has been referenced in discussions of potential international cannabis testing standards, confirmed international operations, investments, or subsidiaries cannot be substantiated based on available public disclosures.

Leadership & Governance

Steep Hill was founded by Chris Hergenrather, who is widely cited as a pioneer in cannabis laboratory testing and has been publicly associated with the company’s early scientific and operational development. Information on the current executive leadership structure is fragmented, and the company does not appear to publish comprehensive governance disclosures comparable to those found in SEC filings.

Based on publicly available sources, the following individuals have been associated with leadership roles, though current titles and tenure cannot be fully verified:

• Chris Hergenrather – Founder
• Anthony Smith – Former Chief Executive Officer
• Michael Kahn – Executive Chairman (historical reference)

The leadership philosophy historically emphasized scientific rigor, regulatory compliance, and independence from cannabis production to preserve objectivity in testing. Current governance practices, board composition, and executive roles are not fully verifiable based on available public sources.